Alembic Pharma dips 5% on disappointing September quarter results
newsdepo.com
Alembic Pharma said that the USFDA recently inspected the company's injectable facility (F-3) site and issued Form 483 with 10 observationsAlembic Pharma dips 5% on disappointing September quarter results
Alembic Pharma said that the USFDA recently inspected the company's injectable facility (F-3) site and issued Form 483 with 10 observations Read more

